BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12733364)

  • 41. Fluorescence in situ hybridization in leukemias: 'the FISH are spawning!'.
    Bentz M; Döhner H; Cabot G; Lichter P
    Leukemia; 1994 Sep; 8(9):1447-52. PubMed ID: 8090024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
    Wu B; Zhou S; Song L; Liu X
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

  • 44. Consistent genetic abnormalities in human cancers as targets for selective therapies.
    Clarkson BD
    Mt Sinai J Med; 1992 Oct; 59(5):400-4. PubMed ID: 1435835
    [No Abstract]   [Full Text] [Related]  

  • 45. Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population.
    Hur M; Park JY; Cho HC; Lee KM; Shin HY; Cho HI
    Clin Lab Haematol; 2006 Jun; 28(3):154-9. PubMed ID: 16706930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance.
    Chim CS; Tam CY; Liang R; Kwong YL
    Cancer; 2001 Jun; 91(12):2222-9. PubMed ID: 11413509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV; Goldman JM
    Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
    Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
    Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NCCN task force report: molecular markers in leukemias and lymphomas.
    Radich JP; Zelenetz AD; Chan WC; Croce CM; Czuczman MS; Erba HP; Horning SJ; Houldsworth J; Smith BD; Snyder DS; Sundar HM; Wetzler M; Winter JN
    J Natl Compr Canc Netw; 2009 Jul; 7 Suppl 4():S1-34, quiz S35-6. PubMed ID: 19635230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province].
    Liu QX; Chen HC; Liu XF; Cao YF; Zhang J; Liu J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Dec; 26(12):975-9. PubMed ID: 16676594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chromosome examinations on six-hour cultures of unstimulated peripheral blood from some patients with childhood leukemia.
    Selypes A; László A
    Acta Paediatr Hung; 1990; 30(1):89-98. PubMed ID: 2317388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
    Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
    Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular methods in diagnosis and monitoring of haematological malignancies.
    Yeung DT; Parker WT; Branford S
    Pathology; 2011 Oct; 43(6):566-79. PubMed ID: 21881536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
    Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
    Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of the polymerase chain reaction for detection of minimal residual disease of hematologic malignancies.
    Roth MS; Terry VH
    Henry Ford Hosp Med J; 1991; 39(2):112-6. PubMed ID: 1890004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of P27(Kip1) and its clinical significance in acute and chronic leukemia].
    Lu RN; Sheng RL; Li JY; Zhu GR; Ding XJ; Zhu LL; Su EB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):291-7. PubMed ID: 15228653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acceleration of chronic myeloid leukemia correlates with calcitonin gene hypermethylation.
    Malinen T; Palotie A; Pakkala S; Peltonen L; Ruutu T; Jansson SE
    Blood; 1991 Jun; 77(11):2435-40. PubMed ID: 2039824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of KIR2DS4 and its variant KIR1D with leukemia.
    Giebel S; Nowak I; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Kyrcz-Krzemien S; Kusnierczyk P
    Leukemia; 2008 Nov; 22(11):2129-30; discussion 2130-1. PubMed ID: 18463675
    [No Abstract]   [Full Text] [Related]  

  • 59. [P15(INK4B) gene methylation in malignant hematopoietic diseases].
    Wu Q; Guo X; Fan H; Zhou T; Tan G; Guo Q; Chen P; Zhang X; Luo G; Xu M
    Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):644-6. PubMed ID: 11877040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
    Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G
    Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.